Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy

Mycoses

Volumn 40, Issue 7-8, 1997, Pages 297-302

  Tortorano, Anna Maria ^a   Viviani, Maria Anna ^a   Rigoni, A L ^a   Cogliati, M ^a   Roverselli, A ^a   Pagano, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Azole susceptibility; Cryptococcosis; Cryptococcus neoformans; Epidemiology; HIV infection; Serotypes

Indexed keywords

CD4 ANTIGEN; FLUCONAZOLE; ITRACONAZOLE;

ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL TRIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEROTYPING;

EID: 0031440739     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1997.tb00235.x     Document Type: Article

References (31)

1. Kwon Chung, K. J., Polacheck, I. & Bennett, J. E. (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neojormans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J. Clin. Microbiol. 15, 535-537.
2. Salkin, I. F. & Hurd, N. J. (1982) New medium for differentiation of Cryptococcus neoformans serotype pairs. J. Clin. Microbiol. 15, 169-171.
3. Dufait, R., Velho, R. & De Vroey, C. (1987) Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation. Mykosen 30, 483.
4. Levitz, S. M. (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13, 1163-1169.
5. Ellis, D. H. & Pfeiffer, T. J. (1990) Natural habitat of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 28, 1642-1644.
6. Fisher, D., Burrow, J., Lo, D. & Currie, B. (1993) Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes. Aust. N.Z. J. Med. 23, 678-682.
7. Speed, B. & Dunt, D. (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21, 28-34.
8. Evans, E. E. (1950) The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular agglutinations. J. Immunol. 64, 423-430.
9. Wilson, D. E., Bennett, J. E. & Bailey, J. W. (1968) Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127, 820-823.
10. Bennett, J. E., Kwon Chung, K. J. & Howard, D. H. (1977) Epidemiologic differences among serotypes of Cryptococcus neoformans. Am. J. Epidemiol. 105, 582-586.
11. Mishra, S. K., Staib, F., Folkens, U. & Fromtling, R. A. (1981) Serotypes of Cryptococcus neoformans strains isolated in Germany. J. Clin. Microbiol. 14, 106-107.
12. Ikeda, R., Shinoda, T., Fukazawa, Y. & Kaufman, L. (1982) Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J. Clin. Microbiol. 16, 22-29.
13. Kwon Chung, K. J. & Bennett, J. E. (1984) Epidemiological differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol. 120, 123-130.
14. Dromer, F., Guého, E., Ronin, O. & Dupont, B. (1993) Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J. Clin. Microbiol. 31, 359-363.
15. Mukamurangwa, P. (1995) Apport de l'étude de Cryptococcus neoformans à l'épidémiologic de la cryptococcose. Doct. Thesis, Universitair Instelling Antwerpen, 171 pp.
16. Drouhet, E., Dupont, B. & Reyes, G. (1986) Antigènes de Cryptococcus neoformans et réponse immunologique dans la cryptococcose, mycose d'actualité et mycose de l'avenir. Bull. Soc. Fr. Mycol. Med. 15, 21-29.
17. Sagone, M., Dromer, F., Pini, G. & Ronin, O. (1993) Cryptococcosis in Italy: serotypes of clinical isolates from patients with or without HIV infection. 2nd International Conference on Cryptococcus and cryptococcosis. Milano, Italy, September 19-23, Abstr. pp. 2-5.
18. Dromer, F., Matoulin, S., Dupont, B., Letenneur, L., Ronin, O., and the French Cryptococcosis Study Group (1996) Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. Clin. Infect. Dis. 23, 91-96.
19. Sukroongreung, S., Nilakul, C., Ruangsomboon, O., Chuakul, W. & Eampokalap, B. (1996) Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Mycopathologia 135, 75-78.
20. Viviani, M. A. & Tortorano, A. M. (1986) Cryptococcosis in patients at risk or affected with AIDS: proposal of a surveillance protocol. Boll. Ist. Sieroter. Milan. 65, 157-160.
21. Viviani, M. A., Tortorano, A. M., Pagano, A., Vigevani, G. M., Gubertini, G., Cristina, S., Assaisso, M. L., Suter, F., Farina, G., Minetti, B., Faggian, G., Caretta, M., Di Fabrizio, N. & Vaglia, A. (1990) European experience with itraconazole in systemic mycoses. J. Am. Acad. Dermatol. 23, 587-593.
22. Viviani, M. A., Rizzardini, G., Tortoráno, A. M., Fasan, M., Capetti, A., Roverselli, A. M., Gringeri, A. & Suter, F. (1994) Lipid-based amphotericin B in the treatment of Cryptococcosis. Infection 22, 137-142.
23. Kabasawa, K., Itagaki, H., Ikeda, R., Shinoda, T., Kagaya, K. & Fukazawa, Y. (1991) Evaluation of a new method for identification of Cryptococcus neoformans which uses serologic tests aided by selected biological tests. J. Clin. Microbiol. 29, 2873-2876.
24. National Committee for Clinical Laboratory Standards (1995) Reference method for broth dilution antifungal susceptibility testing of yeasts; tentative standard. NCCLS Document 27-T. NCCLS, Villanova, PA, USA.
25. Dromer, F., Matoulin, S., Dupont, B., Laporte, A. and the French Cryptococcosis Study Group (1996) Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). Clin. Infect. Dis. 23, 82-90.
26. Dromer, F., Matoulin, S., Garcia-Hermoso, D., Ronin, O., Dupont, B. and the French Cryptococcosis Study Group (1996) Factors associated with Cryptococcus neoformans serotype D infection. 3rd International Conference on Cryptococcus and Cryptococcosis. Paris, France, September 22 26, Abstr. II.4.
27. Naka, W., Masuda, M., Konohana, A., Shinoda, T. & Nishikawa, T. (1995) Primary cutaneous Cryptococcosis and Cryptococcus neoformans serotype D. Clin. Exp. Dermatol. 20, 221-225.
28. Lasagni, A., Riboldi, A. & Berti, E. (1978) A case of cryptococcosis of the skin. Mykosen 21 Suppl. 1, 98-103.
29. Berti, E., Monti, M., Alessi, E., Viviani, M. A. & Tortorano, A. M. (1981) Cryptococcose cutanée primitive. Quelques remarques sur deux nouveaux cas. Bull. Soc. Fr. Mycol. Méd. 10, 207-212.
30. Tortorano, A. M., Roverselli, A., Cogliati, M. & Brasca, M. (1993) Survey of Cryptococcus neoformans susceptibility to antifungals in Northern Italy. 2nd International Conference on Cryptococcus and cryptococcosis. Milano, Italy, September 19-23, Abstr. pp.6-7.
31. Koletar, S. L., Buesching, VV. J. & Fass, R. J. (1995) Emerging resistance to fluconazole among blood and CSF Cryptococcus neoformans isolates. 35th Interscience Conference on Antimicrobials Agents and Chemotherapy, San Francisco, CA, USA, September 17-20, Abstr. E101.